+ All Categories
Home > Health & Medicine > Biliary talk final

Biliary talk final

Date post: 14-Jul-2015
Category:
Upload: mucingroup
View: 80 times
Download: 0 times
Share this document with a friend
Popular Tags:
63
Biliary Tract Disease August 26, 2014 V. Raman Muthusamy, MD, FACG, FASGE Director of Interventional Endoscopy Clinical Professor of Medicine David Geffen School of Medicine at UCLA
Transcript
Page 1: Biliary talk final

Biliary Tract Disease

August 26, 2014

V. Raman Muthusamy, MD, FACG, FASGEDirector of Interventional Endoscopy

Clinical Professor of MedicineDavid Geffen School of Medicine at UCLA

Page 2: Biliary talk final

Gallstones

• Common: about 20-30 million in US• Gender and Ethnic Predisposition- Over 65% are female- Hispanic and Native American

• Lower socioeconomic status• 700,000 annual cholecystectomies in

U.S.• $6.5 billion annual cost

Page 3: Biliary talk final

Ultrasound Images

Page 4: Biliary talk final

Natural History of Gallstones

• Mostly asymptomatic: 70-90%• 2-4% develop symptoms annually- 10-20% with symptoms have CBD stones

• If symptomatic, frequently recurs (40%)• Gracie and Ransohoff- 5 yrs: 10% symptomatic

- 10 yrs: 15% symptomatic- 15 yrs: 18% symptomatic- No sig complications

Ann Intern Med 1983;99:199-205

Page 5: Biliary talk final

Types of Gallstones

• Cholesterol

- Most Common (75%)

• Pigmented: usually black

- 20% stones

• Brown

- More common in Asia

Page 6: Biliary talk final

Stones

Page 7: Biliary talk final

Cholesterol stones

• Obese women• Rapid weight loss: RYGB, lap band• Terminal ileal resection or disease- Crohn’s disease

• Pregnancy: saturation and poor motility• Drugs: estrogen, OCPs, TPN, octreotide• Genetics• Hypertriglyceridemia, DM, ? vagotomy

Page 8: Biliary talk final

Cholesterol Gallstone

• Cholesterol saturation and Dysmotility• Nucleation- Calcium nidus- Defective acidification- Nucleation vs. Anti-nucleation factors

• Growth- Gallbladder dysmotility (TPN,

pregnancy, octreotide)- Gallbladder mucus

Page 9: Biliary talk final

Pigmented Gallstones

• Bilirubin deconjugation and precipitation

- Bacterial β glucuronidase

• Chronic hemolytic disorders

- Sickle cell, thalassemias

• Chronic liver disease: ie. Cirrhosis

• Gallbladder stasis• Older age and women

• Disrupted enterohepatic circulation

- TI resection, Crohn’s disease

Page 10: Biliary talk final

Brown stones

• Seen with chronic infections of biliary tree

- Bacterial and parasitic• Asian-pacific ethnicity

• Prior surgery of biliary tree

- Stasis and dilation of duct system

- Often after cholecystectomy

• Recurrent pyogenic cholangiopathy

Page 11: Biliary talk final

Gallbladder Sludge

• Mixture of crystals and mucus

• Can cause the same symptoms as stones• Can be transient

• Diagnosed on ultrasound

• Nonshadowing

Page 12: Biliary talk final

KUB of calcified gallstones

Page 13: Biliary talk final

CT scan of gallstones

Page 14: Biliary talk final

Complications of Cholelithiasis

• Biliary colic• Cholecystitis

• Fistulization (GB to duodenum)• Mirizzi syndrome

• Cholangitis

• Pancreatitis

• GB cancer

Page 15: Biliary talk final

Biliary Colic

• RUQ, mid-epigastric• Lasts hours not weeks

- Crescendo, plateau, and then relief• Often post-prandial

- Nocturnal awakening

- Many hours after meal

• Nausea and vomiting

• Radiation to shoulder and back

Page 16: Biliary talk final

Acute Cholecystitis

• Duration: hours to days• Cystic duct obstruction

• HIDA scan: Sens/Spec > 90%• Ultrasonography: Sens/Spec > 90%

• Alk phos, transaminases rarely twice normal

• Mortality: 5-10% advanced age, co-morbidities, complications

Page 17: Biliary talk final

Acute Cholecystitis Complications

• Emphysematous cholecystitis

- Gangrenous gallbladder

• Perforation• Mirizzi Syndrome

- Cystic duct stone leading to biliary obstruction

• Cholecystoenteric fistula

- Pneumobilia

- Duodenum, Colon, Jejunum, Stomach

- Gallstone ileus

Page 18: Biliary talk final

Mirizzi’s Syndrome

Cystic Duct Stone Compressing CBD

Page 19: Biliary talk final

Cholescintigraphy (HIDA)False Positives

• Prolonged fasting

• Liver disease

- Tracer absorbed too slowly

• Chronic cholecystitis

• Total parenteral nutrition• Critical illness

Page 20: Biliary talk final

Board Questions

Page 21: Biliary talk final

76 yo male

• In ICU for recent STEMI, moderate failure• On ventilator, stormy course; NPO,

distended abdomen

• No prior abdominal surgeries• Low grade fever, leukocytosis

• Tenderness in RUQ, no rebound• Increasing AST, ALT and alk phos

- Bilirubin normal

Page 22: Biliary talk final

What is the most likely diagnosis??

A. Mirizzi’s syndrome

B. Choledocholithiasis

C. Ascending cholangitis

D. Acalculus cholecystitis

Page 23: Biliary talk final

What is the best therapy in the critically ill patient??

A. Lap cholecystectomy

B. ERCP with sphincterotomy

C. Percutaneous cholecystotomy

D. Observation

Page 24: Biliary talk final

Acalculous Cholecystitis

• Older; male > female• Triad

- Hemodynamic instability

- Prolonged fasting

- Immobility

• Fever, RUQ pain, leukocytosis, tenderness may be absent

• More fulminant course

Page 25: Biliary talk final

Acalculous Cholecystitis

• RUQ sonogram- GB wall > 4 mm*

- Sonographic Murphy’s sign

- Pericholecystic fluid collection

- Sensitivity: 67-92%

- Specificity: > 90%

• CT scan- GB wall > 4 mm

- Subserosal edema

- Intramural gas

- Sloughed mucosa

- Sens / Spec >95%

• Scintigraphy- False (+) and (-)

NB. Ascites without other cause

Page 26: Biliary talk final

Acalculous Cholecystitis

• Treatment- Urgent

cholecystectomy

- Percutaneous drainage

Page 27: Biliary talk final

Cholecystectomy

• Open or laparoscopic: 0.1% mortality

• Laparoscopic: reduction in postoperative LOS and pain

• Complicated presentation, coagulopathy or adhesions->open

• IOC: allows for ID and potential treatment of choledocholithiasis

Page 28: Biliary talk final

Complications of Cholecystectomy

• Overall incidence: ~1% in recent series• Types:

- Bile leak without significant duct injury

- Major duct injury +/- leak• Transection, stricture etc

• Typically treat leaks with ERCP with stent placement for 4-6 weeks without sphincterotomy (90% success rate)

• Endoscopic therapy similar to surgery for major biliary injury except for disconnection

Page 29: Biliary talk final

ERCP with Stent placement for CBD Leak

Before After (Healed)

Page 30: Biliary talk final

Other Treatment Modalities

• Ursodeoxycholic acid

- Patent cystic duct and non-calcified stones

- Small floating stones best response

- High recurrence rate (>50%)

- Risk of pancreatitis and cholangitis• ESWL not approved in U.S.

• Cholecystostomy tube

Page 31: Biliary talk final

Gallbladder Dyskinesia

• Decreased GB ejection (via CCK-HIDA) fraction may predispose to gallstone formation

• Controversial whether cholecystectomy leads to symptomatic improvement

• More common in subjects with functional bowel disorders

Page 32: Biliary talk final

Gallbladder Polyps

• Common: 1-5% of population• > 95% non-neoplastic (mostly cholesterol)

• Follow with ultrasound for 6 month-1 yr intervals

• If growth > 10 mm, cholecystectomy

• If no growth after 2 yrs, can dispense surveillance

• GB polyp (any size) + PSC = surgery

Page 33: Biliary talk final

Gallbladder Polyps

• Cholesterolosis: Most common (60%)

• Adenomyomatosis (25%)

• Inflammatory (10%)

• Adenoma: rare

- May be precursor to GB cancer

Page 34: Biliary talk final

Gallbladder Polyps

• Cholesterolosis

- Cholesterol / TG within epithelial macrophages

- Local or diffuse

- Can be combined with cholesterol polyps

- 10-15% autopsy series

- Ultrasound remains best way to detect

- Rarely thought to be symptomatic

Page 35: Biliary talk final

Cholesterol vs adenomatous polyp

Page 36: Biliary talk final

Gallbladder Polyps

• Adenomyomatosis

- Hypertrophy of the muscle layer

- Usually focal (fundus) although can be diffuse

- Incidental and asymptomatic

- Classic comet tail appearance on US

- Surgery when wall > 10 mm, associated mass or in rare instances with diffuse disease

Page 37: Biliary talk final

“Comet sign” of Adenomyomytosis

Page 38: Biliary talk final

GB Cancer

Incidence: 5000/yr in US; 1-2% of GB surg

Late diagnosis commonSurgery only curative option

- Radical Cholecystectomy

5 yr survival: <10%Associations:

- Female gender, Caucasian race, increasing age- Porcelain gallbladder- PSC and IBD- Anomalous pancreaticobiliary junction (APBJ)- Cholelithiasis- Chronic Salmonella typhi- Adenomatous GB polyps

Page 39: Biliary talk final

Gallbladder Cancer

Page 40: Biliary talk final

Choledocholithiasis

• Can present with biliary colic

• Elevated liver profile • Dilated common bile duct: when chronic

• Jaundice

• Ascending Cholangitis• Pancreatitis

Page 41: Biliary talk final
Page 42: Biliary talk final
Page 43: Biliary talk final
Page 44: Biliary talk final

Ascending Cholangitis• Infection of CBD: Emergency

- Duct usually obstructed: stones, stent, parasite

- Abnormal duct: post-op, stricture, anastomosis

• Usually bacterial: E coli: 25-50%

- Klebsiella: 15-20%; Enterobacter: 5-10%

- Enterococcus: 10-20%• Treatment: Resuscitate

- Antibiotics: Broad spectrum (if ill, cover enterococcus)

- Relieve obstruction: ERCP, perc drain, surgery

Page 45: Biliary talk final

Ascending Cholangitis: 15-50%

Charcot’sTriad

Fever

RUQ Pain

Jaundice

Reynold’s Pentad: Add MS changes, shock

Page 46: Biliary talk final

Choledocholithiasis

• Recurrent biliary colic in the post-cholecystectomy patient

• ERCP for patients with high probability

- 95% success rate

- 5% complication rate

• For low or intermediate probability

- MRCP – usually for low probability

- EUS – often for intermediate probability

Page 47: Biliary talk final

Choledocholithiasis

• Biliary sphincterotomy

• Balloon / basket extraction

• Balloon sphincteroplasty

- For larger stones; usu after small sphincterotomy

• Lithotripsy

- Mechanical (basket)

- Cholangioscopy

• Laser

• Electrohydraulic (EHL)

- Extracorporeal shockwave lithotripsy

Page 48: Biliary talk final

Sphincter of Oddi Dysfunction

• Stenosis or spasm of the Sphincter of Oddi• Persistent / recurrent biliary pain following

cholecystectomy without structural abnormalities

• Idiopathic recurrent pancreatitis- Recent study shows no advantage to dual

sphincterotomy over biliary sphx alone

• Biliary type pain with intact gallbladder and no stones

Page 49: Biliary talk final

Sphincter of Oddi Dysfunction

• Type I:

- biliary type pain, elevated liver enzymes (> 2x nl on two occasions)

- bile duct diameter > 12 mm on ERCP

- delayed contrast drainage > 45 minute• Type II: biliary type pain and 1 or 2 of the

aforementioned criteria

• Type III: biliary type pain only

Rome III criteria: Doesn’t include contrast drainage as a criteria.

Page 50: Biliary talk final

Sphincter of Oddi Dysfunction

• Type I: empiric biliary sphincterotomy

• Type II: sphincter of Oddi manometry (SOM)

- Abnormal in up to 50-63% pts

- Pain relief up to 85% in this subset with biliary sphincterotomy

- Normal SOM and sphincterotomy: controversial

Page 51: Biliary talk final

Sphincter of Oddi Dysfunction

• Type III:

- Less than 10% response to sphincterotomy

- NIH sponsored trial recently published in JAMA shows NO benefit for manometric testing and sphincterotomy

- ERCP +/- SOM no longer recommended

- Consider other treatments for functional bowel disorders

Cotton et al, JAMA 2014, 311:(20)

Page 52: Biliary talk final

Sphincter of Oddi Manometry

Basal pressure > 40 mm HgCorrelates best with presence

of symptoms and relief following sphincterotomy

Page 53: Biliary talk final

Choledochal Cysts

• Congenital anomalies of the biliary tree

• Incidence: 1/100-150,000• 15-100 x more common in Japan

• Females more commonly affected (3-4:1)

• 2/3 cases manifest by age 10• More seen in adults recently

• Classic triad: Abd. Pain, jaundice, palpable mass

Page 54: Biliary talk final

Choledochal Cysts• Type I: (most common) 80-90% of cases.

Fusiform dilation of CBD (segmental or diffuse)

• Type II: Choledochal diverticulum: 2%• Type III: Choledochocele (intraduodenal

dilation): 1-5%• Type IV: Multiple extra +/- intrahepatic

cysts

- 10%, divided into and A and B type• Type V: Multiple intrahepatic dilation

(Caroli’s disease): rare, but up to 20% in some series

Page 55: Biliary talk final

Choledochal Cysts• Association with anomalous union of pancreatic

and biliary ducts (seen in 50-80%)- Recommend cholecystectomy for GB CA risk

• Jaundice, abdominal pain, intraductal stones• At risk for cholangiocarcinoma (esp. I and IV)

- Risk of 10-30%; 20-30 x gen. population

• Surgical excision for most cysts- Type III: Large biliary sphincterotomy

• Caroli's disease associated with congenital hepatic fibrosis, renal tubular ectasia and polycystic kidney disease

Page 56: Biliary talk final

Todani classification

Page 57: Biliary talk final

Board Questions

• 39 yo male presents with pruritis, jaundice and pain

• No prior PMH or PSH• FH is non-contributory• PE: scleral icterus, mid-

epigastric tenderness• LABS: Alk phos: 487,• Bili: 5.2, AST: 164, ALT:

628• CT on right panel

revealed no stones:

Coyle in GASTRO 2010;138:e3–e4

Page 58: Biliary talk final

Board Question

• Endoscopy reveals bulge at ampulla

Coyle in GASTRO 2010;138:e3–e4

Page 59: Biliary talk final

Board Question 1: What is the most likely diagnosis?

• A. Choledocholithiasis• B. Peri-ampullary diverticulum

• C. Choledochal Cyst• D. Ampullary adenoma

• E. None of the above

Page 60: Biliary talk final

Board Question 2: What is the best treatment?

• A. Observation• B. Ampullectomy

• C. Whipple resection• D. Sphincterotomy

• E. None of the above

Page 61: Biliary talk final

Board Question Answer

• This is a choledochal cyst, Type III

• Aka Choledochocele• Can usually be

treated by large, biliary sphincterotomy that unroofs the cyst

Coyle in GASTRO 2010;138:e3–e4

Page 62: Biliary talk final

Summary

• Stone disease: Common- Know the types and pathogenesis- Know the complications and treatment

• Gallbladder polyps- Know the types and natural history

• Acalculous cholecystitis- Recognize and treat

• Choledocholithiasis:- Know how to diagnose and treat

Page 63: Biliary talk final

Summary

• Ascending Cholangitis: Recognize, urgent treatment- Know organisms and causes

• Sphincter of Oddi dysfunction

- Know sub-types and treatment• Choledochal cysts- Know types, natural history and

treatment


Recommended